Retinal Vein Occlusion and Diabetic Macular Oedema Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People aged 18 or older
- People for whom a specific eye medicine called Aflibercept 8mg (also known as EYLEA 8mg) has been recommended by their doctor
- People who are either new to this type of eye treatment, or who have switched from another similar treatment because their previous treatment was not working well enough (requiring very frequent injections)
- People who are covered by social security (French social insurance system)
- People who have given their free and informed consent before taking part in any research activity
Who may not be able to join:
- People who are pregnant or breastfeeding
- People who are under a legal protection arrangement, such as guardianship or curatorship
- People who have a significant type of astigmatism (a particular eye condition) that may affect how eye pressure is measured using a specific testing method
- People where the doctor running the trial believes there is any other reason that could affect the results of the study (confirm with trial site)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Hussam EL CHEHAB, MD, FEBO, Military Hospital of Sainte Anne, Toulon, France
Phone: 04 83 77 20 60
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Intra Ocular Pressure
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.